Rigaku Holdings Co., Ltd.

Rigaku Holdings Co., Ltd. faced notable stock volatility on June 10, 2026, with a significant decline amid broader market trends. Despite recent challenges, the company has achieved impressive annual growth. Financial metrics indicate a substantial market capitalization, though concerns exist regarding its price-to-book ratio and return on equity.

Rigaku Holdings Co., Ltd. experienced notable intraday activity, reaching a high of JPY 2,689.00. Despite recent declines over the week and month, the company has achieved a substantial annual return. Key financial metrics indicate a premium valuation, alongside challenges in profitability reflected in its low return on equity.

Rigaku Holdings Co., Ltd. faced notable volatility, with a significant stock decline today. The company has struggled recently, showing declines over the past week and month, despite impressive annual growth. Financial metrics reveal a high market capitalization and price-to-earnings ratio, but concerning return on equity raises profitability concerns.

Rigaku Holdings Co., Ltd. has shown notable stock performance, gaining 9.01% on May 29, 2026, and achieving a significant 282.43% increase over the past year. Despite this growth, the company faces challenges, including a high price-to-book ratio and a decline in profits over the last year.

Rigaku Holdings Co. has seen notable stock activity, rising significantly on May 22, 2026, amid a positive market backdrop. Despite recent short-term declines, the company has achieved impressive annual growth. Key financial metrics indicate a premium valuation, with a market capitalization of JPY 704,876 million.

Rigaku Holdings Co., Ltd. has seen significant stock performance, achieving a notable intraday high and strong gains over various time frames. The company reported robust net sales and operating profit, maintaining a competitive market position despite a year-over-year profit decline, supported by a solid return on equity.

Rigaku Holdings Co., Ltd. saw a notable stock decline today, contrasting with the Japan Nikkei 225's modest gain. Despite this, the company has achieved a remarkable annual return of 189.54%. Financial metrics indicate strong market positioning, with significant quarterly net sales and a solid operating profit margin.

Rigaku Holdings Co., Ltd. saw its stock price decline significantly today, contrasting with the modest drop in the Japan Nikkei 225. Despite this, the company has achieved a remarkable 222% return over the past year, alongside strong recent growth metrics, though profits have decreased by 17%.

Rigaku Holdings Co., Ltd. has shown notable stock performance, reaching an intraday high and achieving significant annual returns. The company reported record quarterly net sales and a strong operating profit margin, despite a year-over-year profit decline. Rigaku maintains a substantial market capitalization and P/E ratio.

Rigaku Holdings Co., Ltd. has shown remarkable stock performance, gaining 14.5% on April 27, 2026, and achieving a 231.79% return over the past year. The company reported record quarterly net sales and a strong operating profit margin, highlighting its robust position in the Pharmaceuticals & Biotechnology sector.

Rigaku Holdings Co., Ltd. saw its stock price decline today, despite a strong annual performance of 223.18%. The company reported robust quarterly results, with net sales of JPY 34,697 million and an operating profit margin of 34.26%. Rigaku maintains a market capitalization of JPY 289,964 million.

Rigaku Holdings Co., Ltd. has seen notable stock activity, achieving a significant increase today and reaching an intraday high. The company has demonstrated impressive growth over the past month and year, with strong quarterly net sales and operating profit, positioning it as a mid-cap player in the Pharmaceuticals & Biotechnology sector.

Rigaku Holdings Co., Ltd. saw a significant stock decline on April 15, 2026, despite a strong annual performance with a 190.32% return. The company reported record quarterly net sales and a notable operating profit margin, although its return on equity and price-to-book ratio suggest a complex valuation scenario.

Rigaku Holdings Co., Ltd. has experienced notable stock performance, achieving significant gains today and over the past week and month. The company reported record quarterly net sales and a strong operating profit margin, although its return on equity remains at 0.00%. Rigaku's market capitalization stands at JPY 289,964 million.

Rigaku Holdings Co., Ltd. has shown notable stock activity, achieving an intraday high and significant annual returns. The company reported record quarterly net sales and a strong operating profit margin, highlighting its solid market position in the Pharmaceuticals & Biotechnology sector, despite certain financial metrics indicating challenges.

Rigaku Holdings Co., Ltd. has shown impressive stock performance, with significant gains over various timeframes. The company reported robust financial results, including net sales of JPY 34,697 million and an operating profit margin of 34.26%. Its performance has notably outpaced the Japan Nikkei 225 index.

Rigaku Holdings Co., Ltd. has shown strong performance, with a notable intraday high and significant gains over the past week and month. The company reported record quarterly net sales and a solid operating profit margin, although its return on equity remains at 0.00%, reflecting a unique valuation scenario.

Rigaku Holdings Co., Ltd. has experienced notable stock performance, with significant gains over various timeframes, including a 36.83% increase in the past month and a 75.18% return over the past year. However, the company reported flat results in December 2025 and has a concerning return on equity.

Rigaku Holdings Co., Ltd. saw a significant stock price decline amid a challenging trading session. Despite recent setbacks, the company has demonstrated strong annual returns, outperforming the market. However, it faces valuation concerns, highlighted by a notably negative return on equity and a high price-to-book ratio.